Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Canada Cannabis fees rise in line with inflation…
  • Kentucky - United States Bill to ban delta-8 sales to under-21s land on governor’s desk…
  • Oklahoma - United States House approves extension to Medical Marijuana Authority’s powers…
  • Spain Podemos and allies call for hemp regulation…
  • Belgium Positive notifications list updated…
  • Bulgaria Industrial cannabis THC limit could be increased…
  • Germany Public hearing held over decriminalising cannabis…
  • Afghanistan Decree issued to ban hemp cultivation…
  • United States Bills on hemp and CBD regulatory framework reintroduced in the House…
  • Maryland - United States Bill updating definition of hemp and hemp product passes Senate…
  • Kentucky - United States Medical cannabis bill passes Senate and head to House…
  • Luxembourg Council of State issues opinion over cannabis legislation…
View all
News analysis

Health claims in ads for CBD products: the UK rules interpreted

Written by || 8th January 2019 || News analysis | Regulation and legislation | Europe United Kingdom

When can a health claim be made in an advertisement for a CBD product in the UK? CBD-Intel considers how the advertising codes may be legally applied in practice ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents
CBD products in British health stores: UK cities market survey
Cannabis in the UK now medically legal – up to a point
Zero tolerance on THC content: UK regulatory snapshot

CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.

© 2023 Tamarind Media Limited (T/A CannIntelligence)
CannIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CannIntelligence, does not accept any liability or responsibility for information or views published.